猪瘟病毒拮抗干扰素诱导蛋白OASL抗病毒作用的分子机制

基本信息
批准号:31702220
项目类别:青年科学基金项目
资助金额:24.00
负责人:李连峰
学科分类:
依托单位:中国农业科学院哈尔滨兽医研究所
批准年份:2017
结题年份:2020
起止时间:2018-01-01 - 2020-12-31
项目状态: 已结题
项目参与者:于佳慧,张越秀,张玲楷,郑光来,杨倩,王牟平
关键词:
家畜猪瘟病毒干扰素2'5'寡腺苷酸合成酶样蛋白免疫逃逸
结项摘要

Interferons (IFNs) and IFN-stimulated genes (ISGs) play key roles in the host antiviral defense. Recently, we have demonstrated that the porcine 2'-5'-oligoadenylate synthase-like protein (pOASL) is an antiviral ISG against classical swine fever virus (CSFV), an economically important pestivirus of pigs. We have also shown that pOASL is a coactivator of the MDA5-mediated IFN signaling pathway to exert anti-CSFV activity. Intriguingly, the expression level and antiviral activity of pOASL increased and then declined following CSFV infection. Thus, we hypothesize that CSFV may antagonize the antiviral effects of pOASL by regulating its expression. In this proposal, we will investigate the effects on the IRF3 or IFN-mediated pOASL-induction pathway after CSFV infection. Secondly, we will screen the CSFV protein(s) affecting the expression of pOASL, and its effects on the mRNA transcription or protein expression of pOASL will be examined by real-time RT-PCR and Western blotting. Finally, we will elucidate the molecular mechanism of the CSFV protein(s) antagonizing the pOASL expression through affecting the stability of IRF3 or regulating the IFN signaling pathway. This study is expected to reveal the molecular mechanism of CSFV antagonizing the antiviral activity of pOASL, which will facilitate the development of anti-CSFV agents based on pOASL and provide new insights for the control of CSFV infections.

在宿主抗病毒应答中,干扰素诱导蛋白发挥着关键作用。此前我们证实,猪源2’-5’寡腺苷酸合成酶样蛋白(pOASL)是一种具有抗猪瘟病毒活性的干扰素诱导蛋白,通过增强MDA5介导的I型干扰素信号通路而发挥抗病毒效应。同时我们发现,随着猪瘟病毒感染时间的延长,pOASL的抗病毒活性随同其表达量呈先上升、后下降的趋势。据此我们推测,猪瘟病毒可能通过调控pOASL的表达以拮抗其抗病毒作用。本项目首先确定猪瘟病毒感染对干扰素和干扰素调控因子3介导的pOASL产生途径的影响;然后,筛选调控pOASL表达的猪瘟病毒蛋白,并通过定量RT-PCR和免疫印迹试验研究其对pOASL的mRNA转录或蛋白表达的影响;最后,根据猪瘟病毒蛋白对干扰素调控因子3的稳定性和干扰素信号通路的调控,阐明其拮抗pOASL表达的机制。本研究可望揭示猪瘟病毒拮抗pOASL抗病毒作用的分子机制,为猪瘟防控和开发抗病毒制剂提供参考。

项目摘要

在宿主抗病毒应答中,干扰素诱导蛋白发挥着关键作用。此前我们证实,猪源2’-5’寡腺苷酸合成酶样蛋白(pOASL)是一种具有抗猪瘟病毒(CSFV)活性的干扰素诱导蛋白。本研究证实了pOASL通过增强MDA5介导的I型干扰素信号通路而发挥抗病毒效应。同时发现,随着CSFV感染时间的延长,pOASL的抗病毒活性随同其表达量呈先上升、后下降的趋势。此外,利用CRISPR/Cas9基因编辑平台成功构建了敲除IRF3和IFNAR2的PK-15细胞系,检测CSFV感染后干扰素和IRF3诱导pOASL产生的途径;最后,我们证实CSFV编码蛋白Npro与pOASL存在相互作用。本研究可望揭示CSFV拮抗pOASL抗病毒作用的分子机制,为猪瘟防控和开发抗病毒制剂提供参考。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
3

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
4

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017
5

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

DOI:10.2147/DDDT.S163951
发表时间:2018

李连峰的其他基金

相似国自然基金

1

抗猪瘟病毒干扰素刺激基因的鉴定及其抗病毒分子机制的研究

批准号:31572540
批准年份:2015
负责人:仇华吉
学科分类:C1802
资助金额:64.00
项目类别:面上项目
2

非洲猪瘟病毒A528R蛋白拮抗IFN-β产生的分子机制

批准号:31902258
批准年份:2019
负责人:文雪霞
学科分类:C1802
资助金额:21.00
项目类别:青年科学基金项目
3

山羊副流感病毒3型靶向STAT1拮抗I型干扰素抗病毒应答的分子机制

批准号:31902269
批准年份:2019
负责人:孙敏
学科分类:C1802
资助金额:25.00
项目类别:青年科学基金项目
4

ERK通路调控肠道病毒2A蛋白酶对干扰素抗病毒的拮抗作用及其可能的临床应用

批准号:81772184
批准年份:2017
负责人:彭宜红
学科分类:H2102
资助金额:53.00
项目类别:面上项目